Decatur Capital Management Lowers stake in Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX) : Decatur Capital Management reduced its stake in Boston Scientific Corporation by 4.08% during the most recent quarter end. The investment management company now holds a total of 739,905 shares of Boston Scientific Corporation which is valued at $17,676,330 after selling 31,450 shares in Boston Scientific Corporation , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Boston Scientific Corporation makes up approximately 2.28% of Decatur Capital Management’s portfolio.

Other Hedge Funds, Including , Tredje Ap-fonden boosted its stake in BSX in the latest quarter, The investment management firm added 10,947 additional shares and now holds a total of 134,650 shares of Boston Scientific Corporation which is valued at $3,216,789. Boston Scientific Corporation makes up approx 0.13% of Tredje Ap-fonden’s portfolio. Segall Bryant Hamill added BSX to its portfolio by purchasing 10,536 company shares during the most recent quarter which is valued at $251,705. Boston Scientific Corporation makes up approx 0.01% of Segall Bryant Hamill’s portfolio.Blackrock Investment Management boosted its stake in BSX in the latest quarter, The investment management firm added 3,552,349 additional shares and now holds a total of 7,165,917 shares of Boston Scientific Corporation which is valued at $171,193,757. Boston Scientific Corporation makes up approx 0.21% of Blackrock Investment Management’s portfolio.Gilder Gagnon Howe Co boosted its stake in BSX in the latest quarter, The investment management firm added 311 additional shares and now holds a total of 47,178 shares of Boston Scientific Corporation which is valued at $1,124,724. Boston Scientific Corporation makes up approx 0.02% of Gilder Gagnon Howe Co’s portfolio.Partnerre Asset Management Corp boosted its stake in BSX in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 9,107 shares of Boston Scientific Corporation which is valued at $214,743. Boston Scientific Corporation makes up approx 0.11% of Partnerre Asset Management Corp’s portfolio.

Boston Scientific Corporation closed down -0.01 points or -0.04% at $24.11 with 43,39,079 shares getting traded on Tuesday. Post opening the session at $24.16, the shares hit an intraday low of $24.08 and an intraday high of $24.33 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Boston Scientific Corporation reported $0.27 EPS for the quarter, based on the information available during the earnings call on Jul 28, 2016. Analyst had a consensus estimate of $0.27. The company had revenue of $2126.00 million for the quarter, compared to analysts expectations of $2044.88 million. The company’s revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS.

Many Wall Street Analysts have commented on Boston Scientific Corporation. Company shares were Reiterated by Wedbush on Jul 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 25 from a previous price target of $23 .Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 28 from a previous price target of $26 .Company shares were Reiterated by The Benchmark Company on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 31 from a previous price target of $25 .

Boston Scientific Corporation develops manufactures and markets medical devices. The Company offers its products by seven core businesses: Interventional Cardiology which includes Drug-Eluting Coronary Stent Systems Intravascular Imaging devised and Coronary Technology products such as guide wires guide catheters and balloon catheters among others; Peripheral Interventions (PI) which include stents balloon catheters wires peripheral embolization devices and vena cava filters; Cardiac Rhythm Management (CRM) which include implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; Electrophysiology (EP) which include steerable RF ablation catheters intracardiac ultrasound catheters diagnostic catheters delivery sheaths and other accessories; Endoscopy which includes Spyglass System WallFlex Colonic Stents Resolution Clip and Expect Aspiration Needle among others; Urology and Women’s Health and Neuromodulation.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *